Navegar por término DeCS "tasa de supervivencia"

Mostrando ítems 1-7 de 7

Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia

2018- Hernández-Boluda, Juan Carlos; Correa, Juan-Gonzalo; Álvarez-Larrán, Alberto; Ferrer-Marín, Francisca; Raya, José-María; [et al.]
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?

2021-06- Martínez-Cuadrón, David; Serrano, Josefina; Gil, Cristina; Tormo, Mar; Martínez-Sánchez, Pilar; [et al.]
Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease.

2002-06- Tomé Martínez de Rituerto, Santiago; Martínez Rey, Maria del Carmen; González Quintela, Arturo; Gude Sampedro, Francisco; Brage Varela, Antonio; [et al.]
Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry

2019- Salamero, Olga; Martínez-Cuadrón, David; Sobas, Marta; Benavente, Celina; Susana, Vives; [et al.]
Second cancers in MPN: Survival analysis from an international study

2020-03- Marchetti, Monia; Ghirardi, Arianna; Masciulli, Arianna; Carobbio, Alessandra; Palandri, Francesca; [et al.]
Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-alpha. Results of the CML89 trial of the Spanish Collaborative Group on interferon-alpha2a and CML

1999- Steegmann, Juan Luís; Odriozola, Jesús; Rodriguez Salvanés, Francisco; Giraldo, Pilar; García Laraña, José; [et al.]
Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis-insights from a multicenter study

2025-01- Wang, Yu-Hung; Wei, Chao-Hung; Lin, Chien-Chin; Gurnari, Carmelo; Awada, Hussein; [et al.]